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Summary: We have performed a comparative evaluation of two Immuno Radiometrie Assay (IRMA) kits for
parathyrin against an existing Radioimmuno Assay (RIA) technique for the measurement of intact parathyrin.
The analytical evaluation which was performed in line with the ECCLS recommended kit evaluation protocol
showed a marginal improvement in precision with the new assays. There was a substantial improvement in
the theoretical limit of detection utilising the IRMA kits although it may prove difficult to realize this
improvement in practice with individual samples because of differing protein matrices. The evaluation also
demonstrated the degree of parallelism and range of linearity of both kits as well as inaccuracies when
compared with the International Reference Preparation for parathyrin (IRP 79/500) as the accepted standard.
The demonstration of lack of agreement between measured and kit assigned results for standards when cross-
over studies between kits were performed may highlight a possible contributing factor to inaccuracy. Alter-
natively there may be a difference of antisera avidity within the kits for intact parathyrin.
Whilst minor differences in sample stability were demonstrated between the kits, the sample stability was
much improved compared to that for intact parathyrin measurement by RIA. The correlation studies showed
a degree of correlation consistent with other comparisons similarly performed.
Introduction , , · ·. · <>detect intact parathyrin, large parathyrin fragments
The quantitation of parathyrin and its utility in dis- containing the mid region and the C terminal, and
crimination of hypercalcaemic patients has been con- small fragments consisting of the C terminal without
tentious since the capability of detecting the hormone the mid-region. Non-parathyrin proteins may inter-
was first established and controversy has continued fere with binding in these assays causing falsely ele-
to rage despite the development and refinement of vated values and secondly, biologically active com-
antisera to parathyrin (1 — 3). ponents are short lived which can result in apparently
~ . ~ ., U1 . ,, r ,. r - . low values if parathyrin secretion is episodic.Part of the problem m the application of parathyrin
assays to routine clinical practice lies in the very low ^ t x ,. , ,.-,- 1A. ~ . , A./ - ι Λ - ΐ 9 I / I N - π - ι · 11 · ι The low concentration and difficulties of isolating(10 12mol/l) concentrations of biologically active hor- . . . ,, . ~ . .. ' , , , , , , . „ intact parathyrin from immunologically similar com-
mone in the blood but also in the heterogeneity of Γ u t. j j 1 * <· A- . · . f & J ponents have hampered development of assays. Athe circulating hormone. . ± Γ ι ι · ι ι . ι · . ι ^ ·major step forward was achieved by the introduction
In the past, antibodies used in C terminal parathyrin of pre-precipitation, partial purification and concen-
assays have been specific for amino-acid residues tration steps which isolated intact parathyrin and
53 — 84 of the parathyrin molecule. These assays will other N-terminal fragments from the major biologi-
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cally inert C-terminal fragments which made possible
the quantitation of intact parathyrin within the nor-
mal range. There was however still a lack of precision
and lack of sensitivity which did not allow the defi-
nition of a lower limit of normal such that suppressed
parathyrin levels could be adequately defined (3).
The development of IRMA techniques has revolu-
tionised other fields of endocrine hormone assay
where there has been a need for improved detection
limits and imprecision for the clinical application. It
was predicted that a similar benefit would accrue by
application of these techniques to the assay of intact
parathyrin. A number of commercial kits have been
developed in an attempt to achieve this. Here we
describe an analytical assessment of two of the more
popular IRMA kits for intact parathyrin against our
current routine parathyrin assay.
Materials and Methods
Analytical evaluation
The analytical assessment consisted of comparing two IRMA
kits (Kit A and B) for whole molecule parathyrin with an
established RIA whole molecule parathyrin kit (Kit C) currently
in routine use.
Kit A
Ntact® parathyrin IRMA kit product ca. 22800 (Incstar Cor-
poration, Stillwater, Minnesota) was obtained from Immuno
Diagnostic Systems (Usworth Hall, Washington, Tyne & Wear,
or latterly direct from Incstar Ltd., Winnersh, Berkshire).
Kit B
Allegro™ Intact parathyrin immunoassay kit product no. 40-
2170 (Nichols-Institute, San Juan Capistrano, California) was
obtained from Biogenesis Ltd. (Yeomans Way, Bournemouth).
Both kits are of the immunoradiometric assay type, utilizing
two different polyclonal antibodies purified by affinity chro-
matography. The first antibody specific for the mid range and
C terminal portions (parathyrin 39 — 84) is immobilized onto
plastic leads. The second antibody specific for the N terminal
region (parathyrin 1 —34) is labelled with 125I. Intact parathyrin
present in a sample is bound by both the immobilized and
labelled antibodies to form a sandwich complex.
Following incubation, the bead is washed to remove unbound
components and the radioactivity bound to the solid phase is
measured in a gamma counter. The radioactivity of the bead
bound complex is directly proportional to the amount of intact
parathyrin in the sample.
Kit C
Human Ntact® parathyrin by RIA product no. 69065 (Incstar
Corporation, Stillwater, Minnesota). This measures intact para-
thyrin utilising extraction followed by conventional radioim-
munoassay technique. Extraction and concentration of intact
parathyrin in plasma is achieved using specific absorption par-
ticles which remove only intact parathyrin and N terminal
fragments. Following elution of parathyrin from these particles,
assay by RIA is performed.
Following a period of familiarisation with the kits, evaluation
was carried out as detailed adhering where appropriate to the
ECCLS guidelines (4).
An established sample data base was already in existence within
the laboratory, consisting of samples collected and stored under
optimum conditions.
Statistical evaluation
The assay limit of detection was defined as the concentration
corresponding to the 95% confidence limits of counts obtained
for replicates of zero standards assayed in a single batch.
Regression and correlation studies were carried out using stand-
ard Deming regression equations. The straight line model cor-
relation coefficient was used based on the Deming plots.
Results
Imprecision
Ten replicates of pooled human serum were analyzed
in a single batch to assess within batch imprecision.
Overall (between-batch) imprecision was assessed us-
ing the same serum pool assayed in duplicate in each
of 11 assays. The results of within batch and overall
imprecision are shown in table 1. For an equivalent
number of assays, the Ntact RIA kit showed an
overall CV of 14.2% at a mean concentration of 74
ng/1.
Assay limit of detection
Twenty replicate analyses of a zero standard were
made and the limit of detection defined as given in
the method section. The limit of detection was shown
to 2.36 ng/1 for the Ntact IRMA kit and 3.71 ng/1 for
the Allegro kit. The Ntact RIA kit has a limit of
detection of 28 ng/1 based on the same algorithm.
Dose response and parallelism
Using a range of dilutions of the International Ref-
erence Preparation for parathyrin (IRP 79/500) ob-
tained from the National Institute for Biological
Standards and Control, linearity was assessed over
the concentration range 31.25 to 10000 ng/1 (fig. 1).
All dilutions of the IRP were prepared in phosphate
buffered saline (pH 7.4) containing 300 g/1 albumin.
Parallelism was investigated using 2 human plasma
samples known to contain elevated concentrations of
parathyrin. Varying dilutions of these were made in
the kit zero standard. The concentrations obtained
were corrected for the dilution factor and expressed
as a percentage of the concentration measured in the
undiluted sample (tab. 2).
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Fig. 1. Dose response study.
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Standard and quality control cross over
study
Preliminary investigation had suggested that the re-
sults obtained with the IRMA kits were not directly
comparable. To investigate the possible cause of the
discrepancy, standards and quality control materials
from each kit were assayed using the alternative kit
reagents. The results are shown in table 3.
Tab. 3. Cross-over study of parathyrin IRMA kits using kit standards and quality control materials.
Kit standards
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Accuracy
Accuracy was assessed by assaying known concentra-
tions of parathyrin prepared from dilutions of IRP
79/500 in zero standard. The Incstar IRMA kit meas-
ured between 60% and 182% of the calculated dose
at concentrations of 1000 and 62.5 ng/1 respectively;
whilst the Nichols kit measured between 42% and
80% of the calculated dose at the same concentra-
tions.
Kit stability
Standard curves from IRMA kits were compared










Fig. 2. Kit stability study
Δ Allegro kit at delivery
• Allegro kit two weeks post expiry date
D Ntact IRMA kit at delivery
A Ntact IRMA kit two weeks post expiry date
Correlation
Patient samples which had been stored under optimal
conditions were analysed using the IRMA kits. All
samples had previously undergone parathyrin assay
using the Ntact RIA kit and covered a concentration
range 28 — 270 ng/1 by this technique.
For the possible combinations (Nichols vs Incstar
IRMA, Incstar RIA vs Incstar IRMA and Incstar
RIA vs Nichols), straight line correlation coefficients
in excess of 0.9 were obtained for 88 data pairs.
Specimen requirements
Since parathyrin is a labile molecule, specimen collec-
tion and storage are of the utmost importance. Blood
samples from 4 patients were collected into plain glass
bottles for serum harvest and into bottles containing
potassium-EDTA as preservative for plasma harvest.
These samples underwent varying treatment with re-
gard to separation and storage. All sample from an
individual patient were analyzed in a single batch to
obtain the results given in table 4. A difference in
concentration from samples separated within 30 min-
utes at + 4 °C and stored at —20 °C of greater than
(2 χ SDanalyticai) was taken as significant change.
Other factors
Laboratory staff involved in the evaluation were
asked to record their subjective opinions of each kit
with regard to packaging, instructions, ease of use
etc. The cost per patient sample was also calculated.
Discussion
The contribution of parathyrin assay to the differ-
ential diagnosis of patients with hypercalcaemia has
been contentious since its estimation was established.
A number of factors appear to contribute to the
various claims, amongst which are the parathyrin
moiety used as a measure of circulating parathyrin
status and the performance characteristics on the tech-
nique chosen to measure this.
Most commercial endeavour has been invested in
improving the assay of whole molecule parathyrin.
The two commercial kits evaluated here have been
developed utilising IRMA technology (5, 6), and the
manufacturers claim significant improvement in the
analytical and clinical diagnostic utility in hypercal-
caemic patients.
Minor improvements in overall imprecision were
noted for both IRMA kits compared with the current
radioimmunoassay at equivalent concentrations,
which may reflect the avoidance of an extraction
procedure.
The limit of detection for both IRMA kits showed
approximately a 10 fold improvement over the con-
ventional technique and should therefore permit iden-
tification of patients with suppressed levels of para-
thyrin. This improvement was not reflected by a
greater improvement in assay precision but it is pos-
sible that had we assessed RIA precision at a para-
thyrin concentration closer to that used in the IRMA
kit quality assurance material the difference might
have been more marked.
Although standards provided in the kits only range
from 0-2000 ng/1 (Incstar Ntact) or 0-1650 ng/1
(Nichols Allegro), the theoretical working range of
the assays is approximately 5 times this concentration
range. A standard curve prepared from IRP 79/500,
showed acceptable linearity with no evidence of a
high dose hook effect up to 10000 ng/1.
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Separation within 30 min
at +4°C. Store -20°C
Separation within 30 min at
R. T. Store at R. T for 24 h
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R.T. Store —20 °C immediately
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* indicates significant difference from row 1
R. T = Room temperature
Patient samples when diluted showed recoveries as
low as 80%. Neither kit seemed significantly better
than the other. However with the theoretical working
range of 0 — 10000 ng/1, few clinical samples would
require dilution if a wider range of standards were
made available.
Problems experienced in the initial phase of this study
led us to question the comparison of results obtained
by the IRMA techniques. Whilst a significant corre-
lation coefficient was obtained, a few patient samples
appeared grossly discrepant. Crossover of kit stand-
ards and quality control materials showed a similar
discrepancy. Wheter this represents differing assign-
ments for standards against the IRP, or varying anti-
sera avidity is not clear.
It is interesting that a similar discrepancy was shown
in the accuracy study utilising the IRP. Neither kit
quotes the basis of their standardisation and whilst
the Allegro kit underestimated the concentration
across the whole standard range, the Ntact kit ap-
peared to overestimate at lower concentrations and
underestimate at higher concentrations.
Both IRMA kits were shown to be acceptable for use
outwith their quoted expiry dates which is advanta-
geous if regular useage is not envisaged.
Deming analysis showed good correlation between the
concentrations measured by the IRMA kits when
compared with the existing whole molecule assay.
One major point highlighted in this technical evalu-
ation was that of improved sample stability over that
seen in the RIA assay routinely. The existing require-
ment has been for plasma samples collected, separated
and frozen within 30 minutes. After this period a
marked decline in the concentration of intact para-
thyrin measured had been noted (7).
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Utilising the IRMA kits however, a less rigid require-
ment was demonstrated. Standing for up to 2 hours
at room temperature appeared to have little effect on
the measured dose, providing that samples were then
stored frozen. Plasma samples seemed less sensitive
to storage conditions than serum samples. This is in
contrast to the findings of Newman & Ashby (8).
Subjective impressions of both IRMA kits were fa-
vourable compared to the RIA method which involves
an extraction procedure. In terms of hands on time
however, all three assays were comparable. The
IRMA kits were less expensive per patient sample
than the RIA kit although the assay turn round time
is longer for the IRMA kit. In a practical situation
however this fact is irrelevant.
As neither of the IRMA kits under assessment showed
significant technical superiority over the other, the
decision of which kit to use rests soley on the per-
formance in the clinical setting. The clinical assess-
ment is proceeding at present and will be reported on
when completed.
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